Michelle McMurry-Heath, MD, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, BIOTECHNOLOGY INNOVATION ORGANIZATION
Michelle McMurry-Heath, M.D., Ph.D., is the President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C.
Dr. McMurry-Heath is a long-time advocate for innovation, science and patients. She has served in numerous senior leadership roles at Johnson & Johnson since 2014. Most recently, as Vice President of External Innovation and Global Leader for Regulatory Science, she led a global team of 900 employees charting the evidence generation and regulatory strategy across J&J's medical device companies, specializing in using cutting-edge tools and innovative methods to bring new breakthroughs to patients.
McMurry-Heath, a Harvard-educated former senior FDA science official, is a physician and a molecular immunologist who became the first African-American to graduate from Duke's Medical Scientist Training Program. She served as the founding director of the Aspen Institute's Health Biomedical Science and Society Policy Program focused on broadening access to personalized medicine and bolstering international preparedness for pandemic disease threats.
McMurry-Heath served as a science and technology policy fellow at the American Association for the Advancement of Science (AAAS). She also served as lead health and science policy on Capitol Hill for Senator Joe Lieberman, where she drafted legislation to protect the country from biological attacks. Additionally, she oversaw health policy for the Senator's 2004 presidential campaign. Dr. McMurry-Heath sharpened her science policy skills as the Robert Wood Johnson Foundation Health and Society Scholar and as the Macarthur Fellow for Global Health at the Council on Foreign Relations.
Throughout her entire career, she has committed her life to the belief that medical innovation can improve the lives of patients around the world. In her new role at BIO, she looks forward to continuing to partner with bold innovators willing to take on some of society's biggest challenges.
Biotech's Finest Hour
The COVID-19 pandemic has changed the world in fundamental ways, and the biotechnology sector has…
Interactive Plenaries
Science on the Front Lines & on the Front Page
The COVID-19 pandemic has put science front and center for the general public. People want to…
Interactive Super Sessions
11:00 AM - 1:30 PM (PDT)
A Way Forward: Winning the War on COVID through Vaccines
The long-term solution to the pandemic is the availability of vaccines. Yet the development of a…
Fireside Chat with Jim Greenwood and Michelle McMurry-Heath, BIO
Join us for a lively conversation with Jim Greenwood and Michelle McMurry Heath, MD, PhD, as they…
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Join a first of its kind discussion with Black CEO's of biotechnology companies and leaders of BIO…
Interactive Special Programs
BIO DIGITAL: What's Next
Join BIO's Michelle McMurry-Heath as she recaps BIO Digital Week, how to keep the conversation…
The Bio Revolution: Innovations transforming economies, societies, and our lives
Advances in biological sciences, combined with the accelerating development of computing, data…
On Demand Special Programs